Can tobacco use promote HCV-induced miR-122 hijacking and hepatocarcinogenesis?

Medical Hypotheses

Volumn 80, Issue 2, 2013, Pages 131-133

  Zhao, Lijun ^a   Li, Farong ^a   Taylor, Ethan Will ^b  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN G1; DDX3 HELICASE; HELICASE; MICRORNA 122; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; GENE ACTIVATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; RNA BINDING; SIGNAL TRANSDUCTION; TOBACCO; UPREGULATION; VIRUS ACTIVATION; VIRUS GENOME; VIRUS REPLICATION;

ARGONAUTE PROTEINS; CARCINOMA, HEPATOCELLULAR; CYCLIN G1; DEAD-BOX RNA HELICASES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; MODELS, BIOLOGICAL; TOBACCO USE DISORDER; VIRUS REPLICATION;

HEPATITIS C VIRUS; NICOTIANA TABACUM;

EID: 84872296519     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.11.009     Document Type: Article

References (30)

1. Sherman M., Llovet J.M. Smoking, hepatitis B virus infection, and development of hepatocellular carcinoma. J Natl Cancer Inst 2011, 103:1642-1643.
2. Chuang S.C., Lee Y.C., Hashibe M., Dai M., Zheng T., Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010, 19:1261-1268.
3. Kuper H., Tzonou A., Kaklamani E., et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000, 85:498-502.
4. Jangra R.K., Yi M., Lemon S.M. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 2010, 84:6615-6625.
5. Jopling C.L., Norman K.L., Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol 2006, 71:369-376.
6. Machlin E.S., Sarnow P., Sagan S.M. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci USA 2011, 108:3193-3198.
7. Shimakami T., Yamane D., Jangra R.K., et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci USA 2012, 109:941-946.
8. Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P.P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 2011, 146:353-358.
9. Cesana M., Cacchiarelli D., Legnini I., et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369.
10. Tay Y., Kats L., Salmena L., et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011, 147:344-357.
11. Ariumi Y., Kuroki M., Abe K., et al. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J Virol 2007, 81:13922-13926.
12. Sun M., Song L., Zhou T., Gillespie G.Y., Jope R.S. The role of DDX3 in regulating Snail. Biochim Biophys Acta 1813, 2011:438-447.
13. Botlagunta M., Vesuna F., Mironchik Y., et al. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 2008, 27:3912-3922.
14. Zhao L., Li F., Zhang Y., et al. Mechanisms and genes involved in enhancement of HIV infectivity by tobacco smoke. Toxicology 2010, 278:242-248.
15. Hassan M.M., Spitz M.R., Thomas M.B., et al. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 2008, 123:1883-1891.
16. Fujita Y., Shibata A., Ogimoto I., et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 2006, 94:737-739.
17. Garbelli A., Radi M., Falchi F., et al. Targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase as a novel strategy to inhibit viral replication. Curr Med Chem 2011, 18:3015-3027.
18. Angus A.G., Dalrymple D., Boulant S., et al. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J Gen Virol 2010, 91:122-132.
19. Owsianka A.M., Patel A.H. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 1999, 257:330-340.
20. Henke J.I., Goergen D., Zheng J., et al. MicroRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008, 27:3300-3310.
21. Hsu S.H., Wang B., Kota J., et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 2012, 122:2871-2883.
22. Wen W., Ding J., Sun W., et al. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology 2012, 55:1787-1798.
23. Ye X.X., Liu C.B., Chen J.Y., Tao B.H., Zhi-Yi C. The expression of cyclin G in nasopharyngeal carcinoma and its significance. Clin Exp Med 2012, 12:21-24.
24. Jopling C.L. Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans 2008, 36:1220-1223.
25. Sendi H. Dual role of miR-122 in molecular pathogenesis of viral hepatitis. Hepat Mon 2012, 12:312-314.
26. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
27. Young D.D., Connelly C.M., Grohmann C., Deiters A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 2010, 132:7976-7981.
28. Branch A.D., Rice C.M. Antisense gets a grip on miR-122 in chimpanzees. Sci Transl Med 2010, 2:13ps11.
29. Gramantieri L., Ferracin M., Fornari F., et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007, 67:6092-6099.
30. Wang S., Qiu L., Yan X., et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1)-modulated P53 activity. Hepatology 2012, 55:730-741.